Specifically, it can reduce macrophage infiltration and inflammatory cytokine production in the liver and adipose tissues, alleviating metabolic disorders in obese mice by inhibiting TLR3/NLRP3 (NLR family pyrin domain containing 3) inflammasome activation [161]. This evidence concerns the gene NLRP3 and metabolic disease.